Laparoscopic fundoplication is the treatment of choice for gastro-oesophageal reflux disease. Antagonist (Q43006123)

12 November 2017

Laparoscopic fundoplication is the treatment of choice for gastro-oesophageal reflux disease. Antagonist (English)

1 reference

12 November 2017

Galmiche JP

1

1 reference

12 November 2017

Zerbib F

series ordinal

2

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

12 November 2017

1 reference

12 November 2017

51

1 reference

12 November 2017

4

1 reference

12 November 2017

472-474

1 reference

The cost of long term therapy for gastro-oesophageal reflux disease: a randomised trial comparing omeprazole and open antireflux surgery

12 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773388

Helicobacter pylori and gastroesophageal reflux disease: to treat or not to treat?

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773388

Continued (5-year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773388

Management of GERD: medical versus surgical

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773388

Transition from open to laparoscopic fundoplication: the learning curve.

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773388

Outcomes of atypical symptoms attributed to gastroesophageal reflux treated by laparoscopic fundoplication

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773388

Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773388

Lifetime costs of surgical versus medical treatment of severe gastro-oesophageal reflux disease in Finland

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773388

Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome.

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773388

Fate of Nissen fundoplication after 20 years. A clinical, endoscopical, and functional analysis

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773388

Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773388

Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial.

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773388

Quality of life before and after laparoscopic fundoplication.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773388

Long-term management of gastro-oesophageal reflux disease with omeprazole or open antireflux surgery: results of a prospective, randomized clinical trial. The Nordic GORD Study Group.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773388

Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773388

Laparoscopic or conventional Nissen fundoplication for gastro-oesophageal reflux disease: randomised clinical trial. The Netherlands Antireflux Surgery Study Group

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773388

Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773388

Long-term safety and efficacy of omeprazole in gastro-oesophageal reflux disease

16 August 2018

1 reference

12 December 2020

Esophageal motility in reflux disease before and after fundoplication: a prospective, randomized, clinical, and manometric study

1 reference

12 December 2020

Endoscopic treatment of gastroesophageal reflux disease--fact or fancy?

1 reference

12 December 2020

Remission of angina pectoris and dyspnea by fundoplication in gastro-oesophageal reflux disease

1 reference

12 December 2020

Omeprazole for the treatment of posterior laryngitis

1 reference

12 December 2020

Choice of long-term strategy for the management of patients with severe esophagitis: a cost-utility analysis

1 reference

12 December 2020

Effects of omeprazole versus placebo in treatment of noncardiac chest pain and gastroesophageal reflux

1 reference

12 December 2020

The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain

1 reference

12 December 2020

Identifiers

DOI

10.1136/GUT.51.4.472

1 reference

12 November 2017

1 reference

12 November 2017

PubMed publication ID

12235065

1 reference